Systemic or invasive candidosis, unspecified is an infection caused by a type of yeast known as Candida. Candida is a normal inhabitant of the human body and is found in the gastrointestinal tract, skin, and mucous membranes. Under normal circumstances, the body’s immune system is able to keep Candida in check. However, certain conditions can lead to overgrowth of the yeast, resulting in infection. These conditions include diabetes, antibiotic use, chemotherapy, and immunosuppression.
Systemic or invasive candidosis, unspecified is typically diagnosed through a combination of physical examination, laboratory tests, and imaging studies. The physical examination may reveal signs and symptoms of infection, such as fever, rash, and swollen lymph nodes. Laboratory tests may include blood cultures to identify the type of organism causing the infection, as well as testing for antibodies against Candida. Imaging studies, such as X-rays and CT scans, can be used to detect the presence of an infection in the lungs or other organs.
Systemic or invasive candidosis, unspecified must be differentiated from other infections that can cause similar signs and symptoms. These include other types of fungal infections, such as histoplasmosis and cryptococcosis, as well as bacterial infections, such as pneumonia and sepsis.
Treatment of systemic or invasive candidosis, unspecified depends on the severity of the infection and the patient’s underlying medical condition. In mild cases, antifungal medications may be prescribed. In more severe cases, antifungal medications may be given intravenously. In addition, immunosuppressive medications may be given to help the body fight the infection.
The prognosis for systemic or invasive candidosis, unspecified depends on the underlying medical condition of the patient, the severity of the infection, and the timely initiation of treatment. With prompt and appropriate treatment, most patients can expect a full recovery.